Total number of Results for c.35G>T,p.Gly12Val are 43
ASPsiRNA ID Pairing of target region (top) and ASP-siRNA (bottom) Efficacy (mut)(%) Efficacy (wt) (%) Diff Gene Disease Mutation RefSNP Analysis Pubmed ID
ASPsiRNA ID Mutant allele/ASP-siRNA Efficacy
for mutant(%)
Efficacy
for wild (%)
Relative Difference (%) Gene Disease Mutation RefSNP Analysis Pubmed ID
aspsirna0935 GUUGGAGCUGUUGGCGUAG
CAACCUCGACAACCGCAUC
NA NA NA KRAS Cancer c.35G>T,p.Gly12Val rs12191352
12242156
aspsirna2095 UUGUGGUAGUUGGAGCUGU
AACACCAUCAACCUCGACA
20 0 20 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2096 UGUGGUAGUUGGAGCUGUU
ACACCAUCAACCUCGACAA
20 5 15 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2097 GUGGUAGUUGGAGCUGUUG
CACCAUCAACCUCGACAAC
0 8 -8 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2098 UGGUAGUUGGAGCUGUUGG
ACCAUCAACCUCGACAACC
5 0 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2099 GGUAGUUGGAGCUGUUGGC
CCAUCAACCUCGACAACCG
0 25 -25 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2100 GUAGUUGGAGCUGUUGGCG
CAUCAACCUCGACAACCGC
3 0 3 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2101 UAGUUGGAGCUGUUGGCGU
AUCAACCUCGACAACCGCA
10 8 2 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2102 AGUUGGAGCUGUUGGCGUA
UCAACCUCGACAACCGCAU
75 70 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2103 GUUGGAGCUGUUGGCGUAG
CAACCUCGACAACCGCAUC
0 55 -55 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2104 UUGGAGCUGUUGGCGUAGG
AACCUCGACAACCGCAUCC
10 8 2 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2105 UGGAGCUGUUGGCGUAGGC
ACCUCGACAACCGCAUCCG
5 0 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2106 GGAGCUGUUGGCGUAGGCA
CCUCGACAACCGCAUCCGU
5 1 4 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2107 GAGCUGUUGGCGUAGGCAA
CUCGACAACCGCAUCCGUU
5 20 -15 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2108 AGCUGUUGGCGUAGGCAAG
UCGACAACCGCAUCCGUUC
10 33 -23 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2109 GCUGUUGGCGUAGGCAAGA
CGACAACCGCAUCCGUUCU
10 5 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2110 CUGUUGGCGUAGGCAAGAG
GACAACCGCAUCCGUUCUC
13 2 11 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2111 UGUUGGCGUAGGCAAGAGU
ACAACCGCAUCCGUUCUCA
2 15 -13 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2112 GUUGGCGUAGGCAAGAGUG
CAACCGCAUCCGUUCUCAC
25 5 20 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2113 UUGGCGUAGGCAAGAGUGC
AACCGCAUCCGUUCUCACG
3 15 -12 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2114 UGGCGUAGGCAAGAGUGCC
ACCGCAUCCGUUCUCACGG
75 70 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2115 UGGCGUAGGCAAGAGUGCC
ACCGCAUCCGUUCUCACGG
5 0 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2116 UUGUGGUAGUUGGAGCUGU
AACACCAUCAACCUCGACA
20 0 20 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2117 UGUGGUAGUUGGAGCUGUU
ACACCAUCAACCUCGACAA
20 5 15 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2118 GUGGUAGUUGGAGCUGUUG
CACCAUCAACCUCGACAAC
0 8 -8 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2119 UGGUAGUUGGAGCUGUUGG
ACCAUCAACCUCGACAACC
5 0 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2120 GGUAGUUGGAGCUGUUGGC
CCAUCAACCUCGACAACCG
0 25 -25 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2121 GUAGUUGGAGCUGUUGGCG
CAUCAACCUCGACAACCGC
3 0 3 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2122 UAGUUGGAGCUGUUGGCGU
AUCAACCUCGACAACCGCA
10 8 2 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2123 AGUUGGAGCUGUUGGCGUA
UCAACCUCGACAACCGCAU
75 70 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2124 GUUGGAGCUGUUGGCGUAG
CAACCUCGACAACCGCAUC
0 55 -55 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2125 UUGGAGCUGUUGGCGUAGG
AACCUCGACAACCGCAUCC
10 8 2 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2126 UGGAGCUGUUGGCGUAGGC
ACCUCGACAACCGCAUCCG
5 0 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2127 GGAGCUGUUGGCGUAGGCA
CCUCGACAACCGCAUCCGU
5 1 4 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2128 GAGCUGUUGGCGUAGGCAA
CUCGACAACCGCAUCCGUU
5 20 -15 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2129 AGCUGUUGGCGUAGGCAAG
UCGACAACCGCAUCCGUUC
10 33 -23 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2130 GCUGUUGGCGUAGGCAAGA
CGACAACCGCAUCCGUUCU
10 5 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2131 CUGUUGGCGUAGGCAAGAG
GACAACCGCAUCCGUUCUC
13 2 11 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2132 UGUUGGCGUAGGCAAGAGU
ACAACCGCAUCCGUUCUCA
2 15 -13 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2133 GUUGGCGUAGGCAAGAGUG
CAACCGCAUCCGUUCUCAC
25 5 20 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2134 UUGGCGUAGGCAAGAGUGC
AACCGCAUCCGUUCUCACG
3 15 -12 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2135 UGGCGUAGGCAAGAGUGCC
ACCGCAUCCGUUCUCACGG
75 70 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1
aspsirna2136 UGGCGUAGGCAAGAGUGCC
ACCGCAUCCGUUCUCACGG
5 0 5 KRAS Cancer c.35G>T,p.Gly12Val rs12191352
US2005/0176045A1